The drug flibanserin, designed to treat hypoactive sexual desire disorder (HSDD), also known as chronic low libido, is on its way to be evaluated by the Food and Drug Administration.
12 Aug '24 10:39AM
09 Aug '24 16:35PM
09 Aug '24 16:25PM
09 Aug '24 15:37PM